|
Makerere University Research Repository >
College of Health Sciences >
School of Health Sciences >
Research Articles (Health-Sciences) >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/1715
|
| Title: | Effect of HIV-1 infection on malaria treatment outcome in Uganda patients |
| Authors: | Byakika-Kibwika, Pauline
Ddumba, Edward
Kamya, Moses |
| Keywords: | Malaria
HIV/AIDS
Uganda
Antimalarial therapy
Morbidity
Mortality
Sub-Saharan Africa |
| Issue Date: | 2007 |
| Publisher: | Makerere University Medical School |
| Citation: | Byakika-Kibwika, P., Ddumba, E., Kamya, M.R. (2007). Effect of HIV-1 infection on malaria treatment outcome in Uganda patients. African Health Sciences, 7(2). |
| Abstract: | Background: Malaria and HIV-1 infection cause significant morbidity and mortality in sub-Saharan Africa. HIV-1 increases risk for malaria with the risk increasing as immunity declines. The effect of HIV-1 infection on antimalarial treatment outcome is still inconclusive.
Objective: To compare antimalarial treatment outcome among HIV-1 positive and negative patients with acute uncomplicated falciparum malaria treated with chloroquine plus sulfadoxine-pyrimethamine (CQ+SP).
Methods: Ninety eight HIV-1 positive patients aged 18 months or older with acute uncomplicated falciparum malaria were treated with CQ+SP and followed for 28 days to monitor outcome. Treatment outcome of HIV-1 positive patients was compared to that of 193 HIV-1 negative historical controls. The primary study outcome for both groups was treatment failure.
Results: HIV-1 positive patients older than 5 years of age were less likely to have treatment failure compared to HIV-1 negative patients in the same age group (RR 0.59 95% CI 0.4- 0.8, p < 0.001) and HIV-1 positive patients on routine cotrimoxazole prophylaxis were less likely to have treatment failure following CQ+SP treatment compared to HIV negative patients (RR 0.6 95% CI 0.43-0.92, p = 0.006). There was no difference in treatment outcome according to HIV-1 status for children younger than 5 years of age.
Conclusions: Adherence to cotrimoxazole prophylaxis should be reinforced in HIV positive patients and it should be reassessed if these patients present with acute episodes of malaria. |
| URI: | http://hdl.handle.net/123456789/1715 |
| ISSN: | 1680-6905 |
| Appears in Collections: | Research Articles (Health-Sciences)
|
Files in This Item:
| File |
Description |
Size | Format |
|---|
| byakika-chs-res.pdf | | 181Kb | Adobe PDF | View/Open |
|
All items in DSpace are protected by copyright, with all rights reserved.
|
